Covered recipient · General Payments record

HAROLD EDWARD BAYS

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI: 1316953920
CMS profile: 105280
Location: LOUISVILLE, KY

General Payments · PY2018–2024

$252,976.68

Reported across 321 records
CMS publication 2026-01-23

Latest program year · PY2024

$53,008.22

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Consulting Fee	$48,014.05	15
Travel and Lodging	$4,105.19	17
Food and Beverage	$792.17	14
Education	$96.81	3

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
Boehringer Ingelheim Pharmaceuticals, Inc.	$19,246.96	13
Amgen Inc.	$10,808.09	2
Regeneron Pharmaceuticals, Inc.	$8,111.55	14
Boehringer Ingelheim International GmbH	$6,659.06	1
Eli Lilly and Company	$4,976.47	6
Daiichi Sankyo Europe GmbH	$957.40	1
Novo Nordisk AS	$644.86	3
Esperion Therapeutics, Inc.	$453.71	2
Kiniksa Pharmaceuticals International, plc	$450.00	1
Lilly USA, LLC	$382.39	1
Novo Nordisk AS	$317.73	5

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$78,049.18	103
PY2019	$9,654.11	41
PY2020	$16,717.50	8
PY2021	$52,060.79	32
PY2022	$19,733.88	31
PY2023	$23,753.00	57
PY2024	$53,008.22	49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
Amgen Inc.	$5,215.00	08/20/2024	Consulting Fee	Undisputed	01/23/2026	1117503320	CMS
Amgen Inc.	$5,593.09	11/12/2024	Consulting Fee	Undisputed	01/23/2026	1117503322	CMS
Boehringer Ingelheim International GmbH	$6,659.06	10/12/2024	Consulting Fee	Undisputed	01/23/2026	1117962270	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$397.46	01/24/2024	Travel and Lodging	Undisputed	01/23/2026	1117962266	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$85.35	02/29/2024	Travel and Lodging	Undisputed	01/23/2026	1117962256	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$212.40	03/11/2024	Travel and Lodging	Undisputed	01/23/2026	1117962262	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$35.00	04/08/2024	Food and Beverage	Undisputed	01/23/2026	1117962250	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$140.00	04/08/2024	Travel and Lodging	Undisputed	01/23/2026	1117962260	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$12,700.00	04/08/2024	Consulting Fee	Undisputed	01/23/2026	1117962272	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$31.98	04/18/2024	Food and Beverage	Undisputed	01/23/2026	1117962246	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$31.98	04/18/2024	Food and Beverage	Undisputed	01/23/2026	1117962248	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$39.99	04/18/2024	Food and Beverage	Undisputed	01/23/2026	1117962252	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$39.99	04/18/2024	Food and Beverage	Undisputed	01/23/2026	1117962254	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$100.48	04/18/2024	Food and Beverage	Undisputed	01/23/2026	1117962258	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$352.33	04/18/2024	Travel and Lodging	Undisputed	01/23/2026	1117962264	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$5,080.00	11/22/2024	Consulting Fee	Undisputed	01/23/2026	1117962268	CMS
Daiichi Sankyo Europe GmbH	$957.40	05/14/2024	Consulting Fee	Undisputed	01/23/2026	1091119857	CMS
Eli Lilly and Company	$1,562.50	08/07/2024	Consulting Fee	Undisputed	01/23/2026	1134995600	CMS
Eli Lilly and Company	$1,250.00	08/07/2024	Consulting Fee	Undisputed	01/23/2026	1135014603	CMS
Eli Lilly and Company	$625.00	08/07/2024	Consulting Fee	Undisputed	01/23/2026	1135020170	CMS
Eli Lilly and Company	$625.00	08/07/2024	Consulting Fee	Undisputed	01/23/2026	1135021394	CMS
Eli Lilly and Company	$288.97	08/18/2024	Travel and Lodging	Undisputed	01/23/2026	1135014605	CMS
Eli Lilly and Company	$625.00	12/06/2024	Consulting Fee	Undisputed	01/23/2026	1134979720	CMS
Esperion Therapeutics, Inc.	$431.53	04/08/2024	Travel and Lodging	Undisputed	01/23/2026	1129427642	CMS
Esperion Therapeutics, Inc.	$22.18	04/08/2024	Food and Beverage	Undisputed	01/23/2026	1129427644	CMS
Kiniksa Pharmaceuticals International, plc	$450.00	05/22/2024	Consulting Fee	Undisputed	01/23/2026	1154890095	CMS
Lilly USA, LLC	$382.39	12/05/2024	Travel and Lodging	Undisputed	01/23/2026	1135021396	CMS
Novo Nordisk AS	$229.00	11/02/2024	Travel and Lodging	Undisputed	01/23/2026	1096552233	CMS
Novo Nordisk AS	$365.98	11/02/2024	Travel and Lodging	Undisputed	01/23/2026	1096552467	CMS
Novo Nordisk AS	$49.88	11/02/2024	Travel and Lodging	Undisputed	01/23/2026	1096553089	CMS
Novo Nordisk Inc	$99.42	04/26/2024	Food and Beverage	Undisputed	01/23/2026	1096967553	CMS
Novo Nordisk Inc	$121.50	04/30/2024	Food and Beverage	Undisputed	01/23/2026	1097836692	CMS
Novo Nordisk Inc	$32.27	05/21/2024	Education	Undisputed	01/23/2026	1097255892	CMS
Novo Nordisk Inc	$32.27	05/21/2024	Education	Undisputed	01/23/2026	1097270788	CMS
Novo Nordisk Inc	$32.27	05/21/2024	Education	Undisputed	01/23/2026	1097270912	CMS
Regeneron Pharmaceuticals, Inc.	$341.98	04/28/2024	Travel and Lodging	Undisputed	01/23/2026	1143952429	CMS
Regeneron Pharmaceuticals, Inc.	$494.62	07/25/2024	Travel and Lodging	Undisputed	01/23/2026	1114396432	CMS
Regeneron Pharmaceuticals, Inc.	$35.25	07/25/2024	Travel and Lodging	Undisputed	01/23/2026	1114396434	CMS
Regeneron Pharmaceuticals, Inc.	$183.90	08/25/2024	Food and Beverage	Undisputed	01/23/2026	1114396436	CMS
Regeneron Pharmaceuticals, Inc.	$149.30	08/26/2024	Travel and Lodging	Undisputed	01/23/2026	1114396438	CMS
Regeneron Pharmaceuticals, Inc.	$57.75	08/27/2024	Travel and Lodging	Undisputed	01/23/2026	1114396440	CMS
Regeneron Pharmaceuticals, Inc.	$91.00	08/28/2024	Travel and Lodging	Undisputed	01/23/2026	1114396442	CMS
Regeneron Pharmaceuticals, Inc.	$7.78	08/29/2024	Food and Beverage	Undisputed	01/23/2026	1114396444	CMS
Regeneron Pharmaceuticals, Inc.	$29.20	08/29/2024	Food and Beverage	Undisputed	01/23/2026	1114396446	CMS
Regeneron Pharmaceuticals, Inc.	$16.61	08/29/2024	Food and Beverage	Undisputed	01/23/2026	1114396448	CMS
Regeneron Pharmaceuticals, Inc.	$32.16	08/29/2024	Food and Beverage	Undisputed	01/23/2026	1114396450	CMS
Regeneron Pharmaceuticals, Inc.	$1,112.00	10/10/2024	Consulting Fee	Undisputed	01/23/2026	1114396452	CMS
Regeneron Pharmaceuticals, Inc.	$3,336.00	10/10/2024	Consulting Fee	Undisputed	01/23/2026	1114396454	CMS
Regeneron Pharmaceuticals, Inc.	$2,224.00	10/10/2024	Consulting Fee	Undisputed	01/23/2026	1114396456	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.